Table 17:
Target Population: Reference Case Analysis
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total | |
|---|---|---|---|---|---|---|
| Current Scenarioa | ||||||
| Current SCS (usual care) | 176 | 185 | 194 | 204 | 214 | 973 |
| 10-kHz high-frequency SCS | 1 | 1 | 1 | 1 | 1 | 5 |
| Total volume | 177 | 186 | 195 | 205 | 215 | 978 |
| Future Scenarioa,b | ||||||
| Current SCS (usual care) | 168 | 176 | 184 | 191 | 198 | 918 |
| 10-kHz high-frequency SCSb | 9 | 10 | 11 | 13 | 17 | 60 |
| Total volume | 177 | 186 | 195 | 205 | 215 | 978 |
Abbreviation: SCS, spinal cord stimulation.
a
In both scenarios, we made a conservative assumption of a 5% annual increase in the overall number of funded cases.
b
In the future scenario, we assumed that the people who received 10-kHz high-frequency SCS would increase with an uptake rate of 5% annually (5% in year 1 and 25% in year 5).